Feb 25, 2021
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions
Feb 24, 2021
Lilly to Participate in Cowen Health Care Conference
Feb 18, 2021
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
Feb 17, 2021
Kimberly H. Johnson Elected to Lilly Board of Directors
Feb 17, 2021
Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program
Feb 11, 2021
Iterative Scopes Announces Partnership with Eli Lilly and Company to Advance AI Applications for Inflammatory Bowel Disease (IBD) Clinical Trials
Feb 09, 2021
Lilly Appoints Anat Ashkenazi Chief Financial Officer
Feb 04, 2021
Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD/PD Conference
Feb 03, 2021
Lilly to Participate in Guggenheim Healthcare Talks 2021 Oncology Day
Feb 01, 2021
Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients
Jan 29, 2021
Lilly Reports Strong Fourth-Quarter and Full-Year 2020 Financial Results
Jan 28, 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Jan 28, 2021
Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries
Jan 26, 2021
New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death by 70 percent
Jan 22, 2021
Lilly Completes Acquisition of Prevail Therapeutics
Jan 21, 2021
Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents
Jan 19, 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Jan 15, 2021
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Jan 15, 2021
Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement
Jan 14, 2021
Gabrielle Sulzberger Elected to Lilly Board of Directors